News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
2944
Sources here
19
Companies here
26
Search results Stored financial headlines

Active search

2944 matching headlines

Ticker or company: IXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Anterix chief reg & comm officer Guttman-McCabe sells $10m in shares

Christopher Guttman-McCabe, Chief Regulatory & Communications Officer at Anterix Inc. (NASDAQ:ATEX), sold 122,852 shares of common stock for approximately $10 million. This sale, at prices ranging from $78.7255 to $84.4012 per share, adjusts a previous report to correct a clerical error. Following the transaction, …

ATEX main company
Sharemaestro market context Trend signal active 52 weeks +307.7% ATEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Anterix Inc. (ATEX) officer updates Form 4/A after 122,852-share stock sale

Anterix Inc. Chief Reg & Comm Officer, Christopher Guttman-McCabe, updated a Form 4/A filing to correct an earlier report regarding the sale of 122,852 shares of common stock on June 15, 2026. The amendment clarified that an additional 31,415 shares were sold beyond the …

ATEX main company
Sharemaestro market context Trend signal active 52 weeks +307.7% ATEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equinix Inc. stock outperforms competitors on strong trading day

Equinix Inc. (EQIX) shares rose 2.64% to $1,102.10 on Friday, outperforming the broader market which saw declines in the S&P 500 Index and Dow Jones Industrial Average. This marks the third consecutive day of gains for the stock.

EQIX main company
Sharemaestro market context Trend signal active 52 weeks +42.4% EQIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quanterix Corp (QTRX) director-linked trusts buy 99,400 shares in open market

Quanterix Corp (QTRX) director William P. Donnelly, through trusts, indirectly purchased a total of 99,400 common shares in open-market transactions on August 12 and 13, 2026. The purchases were made at weighted average prices of $2.75 and $2.93 per share, respectively, totaling approximately $286,000. …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Netflix Rethinks Gaming After Major Setbacks

This article first appeared on GuruFocus. Netflix (NASDAQ:NFLX) is pulling back further from traditional in-house game development, closing Night School Studio in Los Angeles and Moonloot Games in Helsinki as it concentrates gaming investment around experiences that fit more naturally inside its streaming ecosystem. …

NFLX main company NFLX main company NFLX34 main company NFLX main company NFC main company NFLX main company +1 more
Sharemaestro market context Price below Trend Line 52 weeks -23.3% NFLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

American Century group reports 5.1% AdvanSix (ASIX) stake in Schedule 13G

American Century Investment Management, Inc., along with American Century Companies, Inc. and the Stowers Institute for Medical Research, has reported a 5.1% beneficial ownership stake in AdvanSix Inc. (ASIX) common stock. This Schedule 13G filing indicates that the group collectively holds 1,363,346 shares with …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wix.com Ltd. (WIX) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman

Hagens Berman is investigating a securities class action lawsuit against Wix.com Ltd. (WIX) after a significant drop in its share price. The lawsuit, filed in the wake of disappointing Q1 2026 financial results and a 46% spike in operating expenses, alleges that Wix made …

WIX main company
Sharemaestro market context Price above Trend Line 52 weeks -43.8% WIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Netflix plans to close two gaming studios, including one in Hollywood

Netflix is closing two of its gaming studios, Night School in Hollywood and Moonloot in Helsinki, as part of an organizational restructuring to operate more efficiently. This move follows mixed results in its gaming strategy since expanding into the sector in 2021 and a …

NFLX main company
Sharemaestro market context Price below Trend Line 52 weeks -35.1% · Next-week setup negative 40.1% NFLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What's Going On With Netflix Stock Friday

This article first appeared on GuruFocus. Netflix (NASDAQ:NFLX) shares dipped about 1% on Friday after the streaming company closed two internal game studios, narrowing its push into in-house development as it shifts toward games that tie more closely to its core service. The move …

NFLX main company NFLX main company NFLX34 main company NFLX main company NFC main company NFLX main company +1 more
Sharemaestro market context Price below Trend Line 52 weeks -23.3% NFLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Concentrix Corp (CNXC): Kopernik funds disclose 5.3% beneficial stake

Kopernik Global Investors, LLC and David B. Iben have reported a beneficial ownership of 5.3% in Concentrix Corp (CNXC) common shares, totaling 3,241,584 shares. This stake is held on behalf of their investment advisory clients, with no single client owning more than 5%. The …

CNXC main company
Sharemaestro market context Price below Trend Line 52 weeks -51.5% CNXC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 4.5% - Here's Why

Immix Biopharma (NASDAQ: IMMX) shares dropped 4.5% to $10.43 on Friday, with trading volume significantly below average. This decline followed the company missing its latest quarterly earnings estimate, reporting a loss of $0.18 per share against an expected $0.17 loss. Despite the recent dip, …

IMMX main company
Sharemaestro market context Trend signal active 52 weeks +400.9% IMMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bill Ackman Lost $400 Million on NFLX Stock in 2022 — Now He’s Back With a 3.15M-Share Bet, Saying Netflix Has ‘Won the Streaming Wars’ (UPDATED)

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Editor's Note: The story has been refreshed with the latest market price action and a revised headline. Billionaire investor Bill Ackman is returning to Netflix Inc., taking …

NFLX main company NFLX main company NFLX main company NFLX main company
Sharemaestro market context Price below Trend Line 52 weeks -23.3% NFLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quanterix Insider Bought Shares Worth $286,354, According to a Recent SEC Filing

An insider at Quanterix Corporation (QTRX) recently purchased shares valued at $286,354, according to a new SEC filing. This transaction was published on August 14, 2026, at 04:11 pm EDT. The article also provides recent news on Quanterix, including their Q2 2026 earnings results …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SK hynix faces backlash over potential Solidigm Nasdaq listing

SK hynix is facing significant investor backlash over the potential Nasdaq listing of its U.S. subsidiary, Solidigm, due to concerns about shareholder value erosion and a complex ownership structure. While SK hynix has considerable cash reserves, the move is seen as a way for …

SKHY main company
Sharemaestro market context Stored weekly price path 6 weeks -1.0% · Next-week setup negative 23.7% SKHY stored weekly price path from 10 Jul 2026 to 14 Aug 2026

Helix Acquisition Corp. III Reports Q2 2026 Financial Results in 10-Q Filing

Helix Acquisition Corp. III (NASDAQ: HLXC) has filed its Form 10-Q for the quarter ending June 30, 2026, detailing financial results post its January 2026 IPO. The report highlights a trust account balance of $175,054,966, net income of $1,334,048 for Q2 2026, and a …

HLXC main company
Sharemaestro market context Trend signal started 30 weeks +7.3% · Next-week setup negative 33.3% HLXC stored weekly price path from 23 Jan 2026 to 14 Aug 2026

Wix.com Ltd. (WIX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announced that shareholders of Wix.com Ltd. (WIX) who suffered losses between February 19, 2025, and May 12, 2026, have the opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that Wix made misleading statements …

WIX main company
Sharemaestro market context Price above Trend Line 52 weeks -43.8% WIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SK Hynix, IBD Stock Of The Day, Forming IPO Base But Actionable Now

SK Hynix is the IBD Stock Of The Day as the South Korean memory-chip maker continues to benefit from high demand from AI data centers. Continue Reading

000660 main company SKHY main company
Sharemaestro market context Trend signal active 52 weeks +558.1% · Next-week setup positive 58.0% 000660 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immix Biopharma (IMMX) gains 5.6% stake holder led by Eventide Asset Management

Eventide Asset Management, LLC, through its Eventide Healthcare & Life Sciences Fund, has reported a beneficial ownership of 3,891,019 shares of Immix Biopharma (IMMX) common stock, representing a 5.6% stake. This Schedule 13G filing indicates that Eventide holds sole voting and dispositive power over …

IMMX main company
Sharemaestro market context Trend signal active 52 weeks +400.9% IMMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wix.com (NASDAQ:WIX) Trading Down 6.5% - Here's What Happened

Wix.com (NASDAQ:WIX) shares dropped 6.5% to $74.88 amid low trading volume, continuing a trend of pressure due to concerns over softer guidance, margin pressure, and its AI transition. The company faces a proposed securities class action alleging misleading disclosures about its competitive position and …

WIX main company
Sharemaestro market context Price above Trend Line 52 weeks -43.8% WIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake

Armistice Capital, LLC and Steven Boyd have reported an updated beneficial ownership stake of 8.01% in Orthofix Medical Inc., totaling 3,264,000 shares. This disclosure, made via an Amendment No. 8 to their Schedule 13G, indicates shared voting and dispositive power over these shares, which …

OFIX main company
Sharemaestro market context Price below Trend Line 52 weeks -28.9% OFIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OCUL|Ocular Therapeutix Inc|Price:9.890|Chg%:-0.210

This article provides detailed financial and analytical data for Ocular Therapeutix Inc (OCUL), including its live stock price, chart, news, and a comprehensive stock score. It covers key financial figures, performance over various periods, technical analysis, analyst ratings, and company profile. The data shows …

OCUL main company
Sharemaestro market context Trend signal started 52 weeks -18.4% OCUL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RBC Adjusts Price Target on CorMedix to $14 From $13, Maintains Outperform Speculative Risk Rating

RBC Capital Markets has increased its price target for CorMedix (CRMD) to $14 from $13, while reiterating an Outperform Speculative Risk rating. This adjustment reflects a positive outlook on the company's financial prospects and potential market performance.

CRMD main company
Sharemaestro market context Trend signal ended 52 weeks -44.9% · Next-week setup positive 56.7% CRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains

CorMedix Therapeutics (CRMD) reported strong Q2 2026 results, with adjusted earnings and consolidated revenues surpassing analyst estimates, primarily driven by strong DefenCath sales and the contribution from the acquired Melinta portfolio. Following these positive results, management raised its full-year EBITDA outlook. The stock saw …

CRMD main company
Sharemaestro market context Trend signal ended 52 weeks -44.9% · Next-week setup positive 56.7% CRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Much Upside is Left in SK Hynix, Inc. - Sponsored ADR (SKHY)? Wall Street Analysts Think 48.13%

SK Hynix, Inc. - Sponsored ADR (SKHY) closed the last trading session at $165.67, gaining 8.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. …

000660 main company SKHY main company
Sharemaestro market context Trend signal active 52 weeks +558.1% · Next-week setup positive 58.0% 000660 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Analysts Believe NCR Voyix (VYX) Could Rally 52.65%: Here's is How to Trade

Shares of NCR Voyix (VYX) have gained 2.4% over the past four weeks to close the last trading session at $8.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …

VYX main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% VYX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pantera Capital (DYNC) cuts reported Dynamix Corp holdings to 0% ownership

Pantera Capital Partners LP and Daniel Wayne Morehead have filed an amended Schedule 13G/A, reporting that they no longer beneficially own shares of Dynamix Corp (DYNC). The filing states that their ownership has been reduced to 0 shares, representing 0% of the class, with …

DNMX main company
Sharemaestro market context Trend signal active 39 weeks +0.9% · Next-week setup negative 34.0% DNMX stored weekly price path from 21 Nov 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context